RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Evecxia Therapeutics, Inc.—a clinical-stage neuroscience company developing a novel class of Serotonin Synthesis Amplification therapies—today announced ...
On Oct. 10, the Schroeder Lab, led by Prof. Frank Schroeder, chemistry and chemical biology, published a study detailing a new class of serotonin-containing compounds and another serotonin pathway in ...
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Evecxia Therapeutics—the first company dedicated to realizing the therapeutic potential of Serotonin Synthesis Amplification to treat central nervous ...
YouTube on MSN
What actually causes IBS? The serotonin solution
Functional gastrointestinal disorders, and irritable bowel syndrome (IBS), aren’t just common anymore; they’re becoming the ...
In a report scheduled for publication in the June 2023 issue of the Journal of Affective Disorders, researchers explore the association between the gut microbiome and the efficacy of selective ...
The intricate web of chemical messengers that facilitate communication between neurons represents one of the body’s most complex and fascinating systems. These neurotransmitters, including serotonin, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results